Benedikt Weber

Benedikt Weber

Auto-generated profile, based on publicly available information

Benedikt Weber

Center for Integrated Protein Science Munich at the Department Chemie, Technische Universität München, Lichtenbergstr, 4, 85748 Garching, Germany

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2017 in Amyloid
Verified
Journal Article
Closed access
KMKirsten Gade Malmos
Kirsten Gade Malmos
LBLuis M. Blancas-Mejia
Luis M. Blancas-Mejia
BWBenedikt Weber
Benedikt Weber
JBJohannes Buchner
Johannes Buchner
MRMarina Ramirez-Alvarado
Marina Ramirez-Alvarado
DODaniel Otzen
Daniel Otzen
Thioflavin T (ThT) has been widely used to investigate amyloid formation since 1989. While concerns have recently been raised about its use as a probe specific for amyloid, ThT still continues to be a very valuable tool for studying kinetic aspects of fibrillation and associated inhibition mechanisms. This review aims to provide a conceptual instruction manual, covering appropriate considerations and pitfalls related to the use of ThT. We start by giving a brief introduction to amyloid formation with focus on the morphology of different aggregate species, followed by a discussion of the quality of protein needed to obtain reliable fibrillation data. After an overview of the photochemical basis for ThT’s amyloid binding properties and artifacts that may arise from this, we describe how to plan and analyze ThT assays. We conclude with recommendations for complementary techniques to address shortcomings in the ThT assay.

1 December 2018 in Journal of Molecular Biology
Verified
Journal Article
Closed access
BWBenedikt Weber
Benedikt Weber
MHManuel Hora
Manuel Hora
PKPamina Kazman
Pamina Kazman
CGChristoph Göbl
Christoph Göbl
CCCarlo Camilloni
Carlo Camilloni
JBJohannes Buchner
Johannes Buchner

27 September 2017 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
DPDzana Pasalic
Dzana Pasalic
BWBenedikt Weber
Benedikt Weber
CGChiara Giannone
Chiara Giannone
TATiziana Anelli
Tiziana Anelli
RMRoger Müller
Roger Müller
JBJohannes Buchner
Johannes Buchner
Significance: How protein assemblies with complex topologies are formed is an important question in structural biology. An intriguing example is IgM, a complex of over 1,200 kDa consisting of six antibody subunits (or five in the presence of the J-chain protein). These are arranged in a ring-like structure connected by disulfide bonds. Here, we show that in vitro and in cell culture, a short peptide extension of the IgM heavy chain is sufficient to steer the formation of the hexameric complex. The formation of a disulfide bond triggers conformational changes in the peptide extensions, which involve specific hydrophobic residues. Our study reveals the redox-controlled assembly of a large protein complex via structural rearrangements in a peptide as a design principle.

27 January 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MHManuel Hora
Manuel Hora
MCMartin Carballo-Pacheco
Martin Carballo-Pacheco
BWBenedikt Weber
Benedikt Weber
VMVanessa K. Morris
Vanessa K. Morris
AWAntje Wittkopf
Antje Wittkopf
BRBernd Reif
Bernd Reif
Antibody light chain amyloidosis is a rare disease caused by fibril formation of secreted immunoglobulin light chains (LCs). The huge variety of antibody sequences puts a serious challenge to drug discovery. The green tea polyphenol epigallocatechin-3-gallate (EGCG) is known to interfere with fibril formation in general. Here we present solution- and solid-state NMR studies as well as MD simulations to characterise the interaction of EGCG with LC variable domains. We identified two distinct EGCG binding sites, both of which include a proline as an important recognition element. The binding sites were confirmed by site-directed mutagenesis and solid-state NMR analysis. The EGCG-induced protein complexes are unstructured. We propose a general mechanistic model for EGCG binding to a conserved site in LCs. We find that EGCG reacts selectively with amyloidogenic mutants. This makes this compound a promising lead structure, that can handle the immense sequence variability of antibody LCs.

25 September 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
EHEva Maria Herold
Eva Maria Herold
CJChristine John
Christine John
BWBenedikt Weber
Benedikt Weber
SKStephan Kremser
Stephan Kremser
JEJonathan Eras
Jonathan Eras
JBJohannes Buchner
Johannes Buchner
The antibody Fv module which binds antigen consists of the variable domains VLand VH. These exhibit a conserved ß-sheet structure and comprise highly variable loops (CDRs). Little is known about the contributions of the framework residues and CDRs to their association. We exchanged conserved interface residues as well as CDR loops and tested the effects on two Fvs interacting with moderate affinities (KDs of ~2.5 µM and ~6 µM). While for the rather instable domains, almost all mutations had a negative effect, the more stable domains tolerated a number of mutations of conserved interface residues. Of particular importance for Fv association are VLP44 and VHL45. In general, the exchange of conserved residues in the VL/VHinterface did not have uniform effects on domain stability. Furthermore, the effects on association and antigen binding do not strictly correlate. In addition to the interface, the CDRs modulate the variable domain framework to a significant extent as shown by swap experiments. Our study reveals a complex interplay of domain stability, association and antigen binding including an unexpected strong mutual influence of the domain framework and the CDRs on stability/association on the one side and antigen binding on the other side.

1 November 2018 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
BWBenedikt Weber
Benedikt Weber
MBMatthias J. Brandl
Matthias J. Brandl
MCMaría Daniela Pulido Cendales
María Daniela Pulido Cendales
CBCarolin Berner
Carolin Berner
TPTejaswini Pradhan
Tejaswini Pradhan
JBJohannes Buchner
Johannes Buchner
Despite their importance for antibody architecture and design, the principles governing antibody domain stability are still not understood in sufficient detail. Here, to address this question, we chose a domain from the invariant part of IgG, the CH2 domain. We found that compared with other Ig domains, the isolated CH2 domain is a surprisingly unstable monomer, exhibiting a melting temperature of ~ 44 °C. We further show that the presence of an additional C-terminal lysine in a CH2 variant substantially increases the melting temperature by ~ 14 °C relative to CH2 wt. To explore the molecular mechanism of this effect, we employed biophysical approaches to probe structural features of CH2. The results revealed that Lys101 is key for the formation of three secondary structure elements: the very C-terminal β-strand and two adjacent α-helices. We also noted that a dipole interaction between Lys101 and the nearby α-helix, is important for stabilizing the CH2 architecture by protecting the hydrophobic core. Interestingly, this interaction between the α-helix and C-terminal charged residues is highly conserved in antibody domains, suggesting that it represents a general mechanism for maintaining their integrity. We conclude that the observed interactions involving terminal residues have practical applications for defining domain boundaries in the development of antibody therapeutics and diagnostics.